Gemphire Therapeutics Inc. (118) | Human Resources (22)

Browse by Subcategory

Bonus & Incentive Agreements (8 contracts)
Compensation Agreements (1)
Consulting Agreements (3)
Employment Agreements (8)
Separation Agreements (2)

Recent Contracts

Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on January 18, 2023)
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan Forms of Option Grant Agreements (Filed With SEC on December 22, 2022)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on January 28, 2022)
Employment Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on November 4, 2021)
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated May 1, 2018 and extension of such agreement,... (Filed With SEC on December 31, 2019)
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of December 22, 2022 (Filed With SEC on December 22, 2022)
Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on November 4, 2021)
Employment Agreement, dated as of December 31, 2020, by and between the Registrant and Akash Bakshi (Filed With SEC on April 15, 2021)
Form of Non-Qualified Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
Form of Stock Unit Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
Form of Restricted Stock Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
Form of Incentive Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
Employment Agreement, dated February 11, 2020, by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on February 13, 2020)
2019 Equity Incentive Plan (Filed With SEC on December 31, 2019)
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Seth Reno dated September 30, 2019 (Filed With SEC on October 3, 2019)
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Charles L. Bisgaier dated September 30, 2019 (Filed With SEC on October 3, 2019)
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Steven Gullans dated September 30, 2019 (Filed With SEC on October 3, 2019)
Form of Notice of Grant of Restricted Stock Bonus for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement Consulting... (Filed With SEC on September 3, 2019)
Consulting Agreement by and between Healthcare Capital LLC, owned and managed entirely by John L. Brooks III and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement... (Filed With SEC on September 3, 2019)
First Amendment to Employment Agreement dated as of July 24, 2019 by and between Gemphire and Steve Gullans (Filed With SEC on August 13, 2019)
Employment Agreement by and between the Registrant and Seth Reno (Filed With SEC on March 18, 2019)